Safety and Efficacy of Long-Term Co-Administration of Fenofibrate and Ezetimibe in Patients With Mixed Hyperlipidemia

Safety and Efficacy of Long-Term Co-Administration of Fenofibrate and Ezetimibe in Patients With Mixed Hyperlipidemia James M. McKenney, Michel Farnier, Kwok-Wing Lo, Harold E. Bays, Inna Perevozkaya, Gary Carlson, Michael J. Davies, Yale B. Mitchel, Barry Gumbiner This double-blind long-term extens...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2006-04, Vol.47 (8), p.1584-1587
Hauptverfasser:	McKenney, James M., Farnier, Michel, Lo, Kwok-Wing, Bays, Harold E., Perevozkaya, Inna, Carlson, Gary, Davies, Michael J., Mitchel, Yale B., Gumbiner, Barry
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Anticholesteremic Agents - administration & dosage Anticholesteremic Agents - adverse effects Anticholesteremic Agents - therapeutic use Apolipoproteins Azetidines - administration & dosage Azetidines - adverse effects Azetidines - therapeutic use Cardiology Cholesterol Diabetes Double-Blind Method Drug Administration Schedule Drug Therapy, Combination Ezetimibe Female Fenofibrate - administration & dosage Fenofibrate - adverse effects Fenofibrate - therapeutic use Gallbladder diseases Humans Hyperlipidemia, Familial Combined - blood Hyperlipidemia, Familial Combined - drug therapy Hypolipidemic Agents - administration & dosage Hypolipidemic Agents - adverse effects Hypolipidemic Agents - therapeutic use Lipids Lipids - blood Low density lipoprotein Male Middle Aged Proteins Treatment Outcome Triglycerides
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!